Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-04-17
2007-04-17
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C436S501000, C436S518000
Reexamination Certificate
active
09857739
ABSTRACT:
Sensitive and specific methods are provided for use in detecting the presence of cancer marker proteins in the body fluids of a mammal. Also provided are autoantibodies for use in these methods and immortalized cells, which are a source of the autoantibodies.
REFERENCES:
patent: 4898951 (1990-02-01), Symons
patent: 4937185 (1990-06-01), Webb et al.
patent: 5157020 (1992-10-01), Kay et al.
patent: 5652115 (1997-07-01), Marks et al.
patent: 5726023 (1998-03-01), Cheever et al.
patent: 5876728 (1999-03-01), Kass et al.
patent: 6322989 (2001-11-01), Cohen
patent: 0 236 606 (1992-06-01), None
patent: 09 189702 (1997-07-01), None
patent: WO 92/13065 (1992-08-01), None
patent: WO 93/11236 (1993-06-01), None
patent: WO 93/21529 (1993-10-01), None
patent: WO 94/23728 (1994-10-01), None
patent: WO 96/00084 (1996-01-01), None
patent: WO 96/03502 (1996-02-01), None
patent: WO 97/14794 (1997-04-01), None
patent: WO 99/58978 (1999-11-01), None
patent: WO 00/26668 (2000-05-01), None
von Mensdorff-Pouilly et al, Eur J Cancer. Jul. 1996;32A(8):1325-31.
Gourevitch et al, Br J Cancer. Oct. 1995;72(4):934-8.
Petrarca et al, Eur J Cancer. Nov. 1996;32A(12):2155-63.
Definition of “moncyte” in On-line Medical Dictionary downloaded on Feb. 5, 2005 from url..cnacerweb.ncl.ac.uk.
Voet et al., (1990, Biochemistry, pp. 1096, and 1098 only).
Voet et al., (1990, Biochemistry, p. 78 only).
Janeway et al., (Immunobiology downloaded from url.ncbi.nlm.nih.gov/books, total 2 pages).
Rao, S.G., “Detection of Human Ovarian Tumor Associated Antigens by Autologous Antibodies Isolated from Ovarian Carcinoma Ascites Fluid”;Proceedings of the American Association for Cancer Research Annual Meeting, 1987, vol. 28, p. 358.
Fishman, P., “Application of autoantibodies to cancer therapy: A new concept”,The 9thInternational Congress of Immunology, 1995, p. 664.
Kutteh, W.H., et al., “Immunologic characterization of tumor markers in human ovarian cancer cell lines”;Journal of the Society for Gynecologic Investigation, 1996, vol. 3, No. 4, pp. 216-222.
Houghton et al.; “Detection of Cell Surface and Intracellular Antigens by Human Monoclonal Antibodies—Hybrid Cell Lines Derived from Lymphocytes of Patients with Malignant Melanoma*”;J. Exp. Med.; vol. 158, Jul. 1983; pp. 53-65.
Rao et al.; “Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid”;Am J Obstet Gynecol; Jul. 1988; vol. 159, No. 1; pp. 94-98.
Petrarca, C., “Human Antibodies Against the Polymorphic Epithelial Mucin in Ovarian Cancer Patients Recognise a Novel Sequence in the Tandem Repeat Region”;European Journal of Cancer, vol. 32A, No. 12, pp. 2155-2163, 1996.
Von Mensdorff-Pouilly, S., “Humoral Immune Response to Polymorphic Epithelial Mucin (MUC-1) inpatients with Benign and Matignant Breat Tumours”;European Journal of Cancer, vol. 32A, No. 8, pp. 1325-1331, 1996.
Gourevitch, MM; “Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients”;British Journal of Cancer, 72, pp. 934-938; (1995).
Sahin et al.; PNAS, 1995, vol. 92, pp. 11810-11813.
Scanlan et al.; International Journal of Cancer, 1998, vol. 76, pp. 652-658.
Petrakou et al.; International Journal of oncology, 1997, vol. 11, suppl. p. 902.
Koterra et al.; Caner Research, 1994, vol. 54, pp. 2856-2860.
Abstract of Mensdorf-Pouilly et al.; Anticancer Research, Nov.-Dec. 1997, vol. 17, p. 4184.
Denton et al.; Cancer Letters, 1993, vol. 70, pp. 143-150.
Zisman et al.; Journal of Urology, 1995, vol. 154, pp. 1052-1055.
Deguchi et al.; Int. Arch. Allergy Appl. Immunol., 1988, vol. 87, pp. 313-316.
Abstract of Yamamoto et al.; Proc. Amer. Soc. Cancer Res., Mar. 1997, p. 564.
Disis et al.; Journal of Clinical Oncology, 1997, vol. 15, pp. 3363-3367.
Croce et al.; Cancer. Immunol. Immunother., 1995, vol. 40, pp. 132-137.
Green et al.; European Journal of Cancer, 1994, vol. 30A, pp. 580-584.
Stearns et al.; Breast Cancer Research and Treatment, Feb. 8, 1998, vol. 52, pp. 239-259.
Kawahara; Cancer, 1986, vol. 58, pp. 2008-2012.
Abstract of Hayes; Anticancer Drugs, 1995, vol. 6, suppl. 2, pp. 26-27.
Abstract of Pandha et al.; Cancer Gene Therapy, 1997, vol. 4, No. 5, p. 310.
Bhatti et al.; Journal of Tumor Marker Oncology, Summer-1994, vol. 9, pp. 125-131.
Aparecida et al., “Value of CEA Level Determination in Gallbladder Bile in the Diagnosis of Liver Metastases Secondary to Colorectal Adenocarcinoma”, Sao Paulo Medical Journal, 2001, vol. 119, No. 3, pp. 110-113.
Apostolopoulos et al., Nature Medicine, 1998, vol. 4, pp. 315-320.
Baechstrom, et al., “Purification and Characterization of Sialyl-Le—Carrying Mucins of Human Bile; Evidence for the Presence of MUC1 and MUC3 Apoproteins”, The Journal of Biological Chemistry, 1994, vol. 269, No. 20, pp. 14430-14437.
Beatty, et al., “Biochemical Characterization of the Soluble Form of Tumor Antigen MUC1 Isolated from Sera and Ascites Fluid of Breast and Pancreatic Cancer Patients”, Clinical Cancer Research, 2001, vol. 7, pp. 781-787.
Hill et al., “Nature of Carcinoembryonic Antigen Purified From Malignant Ascitic Fluid of Serous Cystadenocarcinoma of the Ovary”, Molecular Immunology, 1981, vol. 18, No. 7, pp. 647-653.
Karanikas, et al. J Clin Invest Dec. 1, 1997, vol. 100, No. 11, pp. 2783-2792.
Kuralay, et al., Diagnostic Usefulness of Tumour Marker Levels in Pleural Effusions of Malignant and Benign Origin, Clinica Chimica Acta, 2000, vol. 300, pp. 43-55.
Lafond, R.E., et al., “Autoantibodies to c-myc protein: elevated levels in patients with African Burkitt's lymphoma and normal Ghanians”,Autoimmunity, vol. 13, No. 3, 1992, pp. 215-224.
Lai, et al., “Presence of Serum Anti-P53 Antibodies is Associated with Pleural Effusions and Poor Prognosis in Lung Cancer Patients”, Clinical Cancer Research, 1998, vol. 4, pp. 3025-3030.
Lawniczak, et al., “The Search for Tumor-Associated Proteins in Pleural Effusions by Means of Monoclonal Antibodies and a Dot Blot Assay”, Lung, 1992, vol. 170, pp. 65-74.
Montenarh, et al., “P53 Autoantibodies in the Sera, Cyst and Ascitic Fluids of Patients with Ovarian Cancer”, International Journal of Oncology, 1998, vol. 13, pp. 605-610.
Nery, et al., “Isolation and Partial Characterization of Macromolecular Urinary Aggregates Containing Carcinoembryonic Antigen-Like Activity”, Br J. Cancer, 1974, vol. 29, No. 413.
Nustad et al., “Epitopes on CA 125 from Cervical Mucus and Ascites Fluid and Characterization of Six New Antibodies”, pp. 303-314.
Pavelic et al., Anticancer Reasearch, 1991, vol. 11, pp. 1421-1428.
Rusciano, “Concomitant Purification of Prostatic Carcinoma Tumor Markers from Human Seminal Fluid Under Nondenaturing Conditions”, Clinical Chemistry, 1988, vol. 34, No. 12, pp. 2528-2532.
Sandrin et al., Glycoconjugate Journal, 1997, vol. 14, pp. 97-105.
Schneider, J. “P53 Protein, EGF Receptor, and Anti-P53 Antibodies in Serum from Patients with Occupationally Derived Lung Cancer”, British Journal of Cancer, 1999, vol. 80, No. 12, pp. 1987-1994.
Shibata, et al., “Purification and Characterization of Prostate Specific Antigen from Human Urine”, Biochimica et Biophysica Acta, 1997, vol. 1336, pp. 425-433.
Sokoloff, et al., “A Dual-Monoclonal Sandwich Assay for Prostate-Specific Membrane Antigen: Levels in Tissues, Seminal Fluid and Urine”, The Prostate, 2000, vol. 43, pp. 150-157.
Stubbs, et al., “Faecal Carcinoembryonic Antigen (CEA) in Patients with Large Bowel Cancer”, European Journal of Surgical Oncology, 1987, vol. 13, pp. 433-436.
Tondini, et al., “Comparison of CA15-3 and Carcinoembryonic Antigen in Monitoring the Clinical Course of Patients with Metastatic Breast Cancer”, Cancer Research, 1988, vol. 48, No. 14, pp. 4107-4112.
Toth, et al., “A Carcinoembryonic Antigen (CEA)
Graves Catherine Rosemund
Price Frances Margaret
Price Michael Rawling
Robertson John Forsyth Russell
Kilpatrick & Stockton LLP
University of Nottingham
Yu Misook
LandOfFree
Cancer detection method and reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer detection method and reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer detection method and reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3803594